Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

SAN MATEO, California, December 20 /PRNewswire/ --

NetSuite Inc. (NYSE: N) announced today the initial public offering of 6,200,000 shares of its common stock at a price of US$26.00 per share. NetSuite and certain selling stockholders have also granted the underwriters a 30-day option to purchase up to an additional 930,000 shares to cover over-allotments. NetSuite's common stock will begin trading on the New York Stock Exchange under the symbol "N" on Thursday, December 20, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20021024/SFTH024LOGO)

Credit Suisse Securities (USA) LLC acted as sole book-running manager for the offering and W.R. Hambrecht + Co., LLC acted as co-manager.

MINNEAPOLIS, December 19 /PRNewswire/ --

Nonin Medical, Inc., a leading innovator of physiological monitoring solutions, received the 2007 Industry Best Practices Award for Product Differentiation Innovation from Frost & Sullivan. Frost & Sullivan recognizes outstanding industry achievements and the Awards are recognized worldwide by the media, the investment community and end-user markets. The global growth consulting company honored Nonin for its pioneering vision that has transformed the vital sign monitoring industry and brought powerful, portable and easy-to-use pulse oximetry technology to more people and applications worldwide.

JEFFERSON, North Carolina, December 19 /PRNewswire/ --

Next Safety, Inc., a leader in developing pulmonary drug delivery devices, today announced verification of a significant breakthrough in pulmonary science that provides high efficacy delivery of drugs to the lungs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070615/CLF038LOGO )

Advanced optical characterization techniques performed by a third party laboratory showed that 99.8% of the droplets delivered by Next Safety's pulmonary drug delivery devices were between one and three microns in diameter, and the droplets separated sufficiently in space and time to be absorbed into the alveoli of the lungs.

TORONTO, December 19 /PRNewswire/ -- GuestLogix Inc. (TSX-V: GXI), the leading provider of on-board retail technology and solutions to the airline industry, today announced that Germany's leading no-frills airline, Germanwings of Cologne/Bonn Germany, will be using GuestLogix' Mobile Virtual Store(TM) to process on-board cash, credit and debit card purchases on flights to over 66 destinations in Europe. The deal was secured by GuestLogix' global business partner LSG Sky Chefs, a wholly-owned subsidiary of Deutsche Lufthansa AG (Xetra: WKN 823212).

NEW YORK, December 19 /PRNewswire/ --

-- Record strength concrete poured in New York

-- Dramatic 40% reduction in greenhouse gases

One of the biggest breakthroughs in construction technology --- the innovative iCRETE(TM) system, offering record strength concrete and dramatic environmental benefits is being used to build the Freedom Tower at Ground Zero in New York City. Both the 1,776 foot-tower, as well as the 186-foot inner safety core supporting the superstructure, will be built with iCRETE.

GREENWICH, Conn., HOUSTON and LONDON, December 19 /PRNewswire/ --